Impact factors for microinvasion in intrahepatic cholangiocarcinoma: A possible system for defining clinical target volume

International Journal of Radiation Oncology Biology Physics

Volumn 78, Issue 5, 2010, Pages 1427-1436

  Bi, Ai Hong ^a   Zeng, Zhao Chong ^a   Ji, Yuan ^a   Zeng, Hai Ying ^a   Xu, Chen ^a   Tang, Zhao You ^a   Fan, Jia ^a   Zhou, Jian ^a   Zeng, Meng Su ^a   Tan, Yun Shan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Clinical target volume; Conformal radiotherapy; Intrahepatic cholangiocarcinoma; Microinvasion; Pathologic characteristics

Indexed keywords

CHOLANGIOCARCINOMA; CLINICAL TARGET VOLUMES; CONFORMAL RADIOTHERAPY; MICROINVASION; PATHOLOGIC CHARACTERISTICS;

AMINO ACIDS; CARBOHYDRATES; OPTICAL FLOWS; PATHOLOGY; PHOSPHATASES; RADIOGRAPHY; RADIOTHERAPY;

TUMORS;

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; CA 19-9 ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; IOHEXOL; TUMOR MARKER;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; INTRAHEPATIC CHOLANGIOCARCINOMA; LIVER CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROSCOPY; PRIORITY JOURNAL; SCORING SYSTEM; SENSITIVITY ANALYSIS; TUMOR VOLUME;

ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASES; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CA-19-9 ANTIGEN; CHOLANGIOCARCINOMA; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; LIVER; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; SENSITIVITY AND SPECIFICITY; TUMOR BURDEN;

EID: 78549264408     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.09.069     Document Type: Article

References (22)

1. F. Giuliante, R. Gauzolino, and M. Vellone Liver resection for intrahepatic cholangiocarcinoma Tumori 91 2005 487 492
2. B.G. Czito, M.S. Anscher, and C.G. Willett Radiation therapy in the treatment of cholangiocarcinoma Oncology (Williston Park) 20 2006 873 884 discussion 886-878, 893-875
3. S. Connor, E. Barron, and D.N. Redhead Palliation for suspected unresectable hilar cholangiocarcinoma Eur J Surg Oncol 33 2007 341 345
4. D.E. Heron, D.E. Stein, and D.J. Eschelman Cholangiocarcinoma: The impact of tumor location and treatment strategy on outcome Am J Clin Oncol 26 2003 422 428
5. D.E. Stein, D.E. Heron, and E.L. Rosato Positive microscopic margins alter outcome in lymph node-negative cholangiocarcinoma when resection is combined with adjuvant radiotherapy Am J Clin Oncol 28 2005 21 23
6. Z.C. Zeng, Z.Y. Tang, and J. Fan Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients Cancer J 12 2006 113 122
7. R. Golfieri, E. Giampalma, and M. Renzulli Unresectable hilar cholangiocarcinoma: Multimodality approach with percutaneous treatment associated with radiotherapy and chemotherapy In Vivo 20 2006 757 760
8. U.M. Schleicher, G. Staatz, and G. Alzen Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors Strahlenther Onkol 178 2002 682 687
9. E. Ben-Josef, D. Normolle, and W.D. Ensminger Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies J Clin Oncol 23 2005 8739 8747
10. J. Petera, Z. Papik, and M. Zouhar The technique of intensity-modulated radiotherapy in the treatment of cholangiocarcinoma Tumori 93 2007 257 263
11. S. Laurent, E. Monsaert, and T. Boterberg Feasibility of radiotherapy with concomitant gemcitabine and oxaliplatin in locally advanced pancreatic cancer and distal cholangiocarcinoma: A prospective dose finding Phase I-II study Ann Oncol 8 2009 1369 1374
12. R.V. Tse, M. Hawkins, and G. Lockwood Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664
13. Wang MH, Ji Y, Zeng ZC, et al. Impact Factors for Microinvasion in Patients with Hepatocellular Carcinoma: Possible Application to the Definition of Clinical Tumor Volume. Int J Radiat Oncol Biol Phys. In press. doi:10.1016/j.ijrobp.2009.01.057.
14. M. Kanematsu, H. Hoshi, and T. Yamada Overestimating the size of hepatic malignancy on helical CT during arterial portography: Equilibrium phase CT and pathology J Comput Assist Tomogr 21 1997 713 719
15. X.P. Zhou, Z.W. Quan, and W.M. Cong Micrometastasis in surrounding liver and the minimal length of resection margin of primary liver cancer World J Gastroenterol 13 2007 4498 4503
16. C.R. Kelsey, T. Schefter, and S.R. Nash Retrospective clinicopathologic correlation of gross tumor size of hepatocellular carcinoma: Implications for stereotactic body radiotherapy Am J Clin Oncol 28 2005 576 580
17. J.K. Heimbach, G.J. Gores, and M.G. Haddock Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma Transplantation 82 2006 1703 1707
18. S. Miwa, S. Miyagawa, and A. Kobayashi Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery J Gastroenterol 41 2006 893 900
19. M. Ohtsuka, H. Ito, and F. Kimura Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival Br J Surg 89 2002 1525 1531
20. M. Aljiffry, A. Abdulelah, and M. Walsh Evidence-based approach to cholangiocarcinoma: a systematic review of the current literature J Am Coll Surg 208 2009 134 147
21. V. Bhudhisawasdi, K. Muisuk, and P. Areejitranusorn Clinical value of biliary alkaline phosphatase in non-jaundiced cholangiocarcinoma J Cancer Res Clin Oncol 130 2004 87 92
22. V. Wiwanitkit Activated partial thromboplastin time abnormality in patients with cholangiocarcinoma Clin Appl Thromb Hemost 10 2004 69 71